The prognostic value of expression of HIF1α, EGFR and VEGF-A, in localized prostate cancer for intermediate- and high-risk patients treated with radiation therapy with or without androgen deprivation therapy
Published inRadiation oncology, vol. 7, 66
Publication date2012
Abstract
Keywords
- Aged
- Aged, 80 and over
- Androgen Antagonists/therapeutic use
- Disease-Free Survival
- Humans
- Hypoxia-Inducible Factor 1, alpha Subunit/biosynthesis
- Immunohistochemistry
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Neoplasm Grading
- Prognosis
- Proportional Hazards Models
- Prostatic Neoplasms/metabolism/mortality/therapy
- Radiotherapy
- Receptor, Epidermal Growth Factor/biosynthesis
- Risk Factors
- Tumor Markers, Biological/analysis
- Vascular Endothelial Growth Factor A/biosynthesis
Affiliation
- Faculté de médecine / Section de médecine fondamentale / Département de médecine génétique et développement
- Faculté de médecine / Section de médecine fondamentale / Département de pathologie et immunologie
- Faculté de médecine / Section de médecine clinique / Département de radiologie et informatique médicale
Research group
Citation (ISO format)
WEBER, Damien et al. The prognostic value of expression of HIF1α, EGFR and VEGF-A, in localized prostate cancer for intermediate- and high-risk patients treated with radiation therapy with or without androgen deprivation therapy. In: Radiation oncology, 2012, vol. 7, p. 66. doi: 10.1186/1748-717X-7-66
Main files (1)
Article (Published version)
Identifiers
- PID : unige:27569
- DOI : 10.1186/1748-717X-7-66
- PMID : 22546016
ISSN of the journal1748-717X